Brandes Investment Partners’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.4M | Buy |
|
|||||
|
2025
Q1 | $44.4M | Buy |
|
|||||
|
2024
Q4 | $22.8M | Buy |
|
|||||
|
2024
Q3 | $18M | Sell |
|
|||||
|
2024
Q2 | $20.9M | Buy |
|
|||||
|
2024
Q1 | $24.7M | Sell |
|
|||||
|
2023
Q4 | $21.7M | Buy |
|
|||||
|
2023
Q3 | $14.9M | Buy |
|
|||||
|
2023
Q2 | $21.2M | Sell |
|
|||||
|
2023
Q1 | $13.2M | Sell |
|
|||||
|
2022
Q4 | $11.9M | Sell |
|
|||||
|
2022
Q3 | $13.5M | Sell |
|
|||||
|
2022
Q2 | $8.86M | Buy |
|
|||||
|
2022
Q1 | $20.4M | Buy |
|
|||||
|
2021
Q4 | $21M | Sell |
|
|||||
|
2021
Q3 | $31.8M | Buy |
|
|||||
|
2021
Q2 | $21.8M | Buy |
|
|||||
|
2021
Q1 | $26M | Sell |
|
|||||
|
2020
Q4 | $19.8M | Buy |
|
|||||
|
2020
Q3 | $14.3M | Buy |
|
|||||
|
2020
Q2 | $12M | Sell |
|
|||||
|
2020
Q1 | $13M | Sell |
|
|||||
|
2019
Q4 | $27.6M | Sell |
|
|||||
|
2019
Q3 | $25.7M | Sell |
|
|||||
|
2019
Q2 | $19.6M | Sell |
|
|||||
|
2019
Q1 | $10.2M | Sell |
|
|||||
|
2018
Q4 | $18.4M | Buy |
|
|||||
|
2018
Q3 | $27.8M | Buy |
|
|||||
|
2018
Q2 | $30.5M | Buy |
|
|||||
|
2018
Q1 | $35.1M | Buy |
|
|||||
|
2017
Q4 | $27.1M | Buy |
|